Pancreatin PCD Pharma Franchise Company
Cafoli Lifecare is a reliable Pancreatin PCD pharma franchise company in India, offering 8 Pancreatin formulations across tablets and capsules within its gastro and digestive-enzyme portfolio. All products are manufactured at WHO-GMP certified, DCGI-approved facilities and offered to franchise partners with exclusive district-wise monopoly rights.
What is Pancreatin?
Pancreatin is a pancreatic enzyme preparation containing a mixture of lipase, amylase and protease. It is used as pancreatic enzyme replacement therapy: the lipase digests fats, the amylase digests carbohydrates and the protease digests proteins, supplementing or replacing the enzymes normally secreted by the pancreas. Because these enzymes are inactivated by gastric acid, therapeutic preparations are enteric-coated so that they survive the stomach and release their contents in the alkaline duodenum where digestion takes place. It is used in pancreatic exocrine insufficiency and in enzyme combinations for functional digestive complaints. Compound information is available on PubChem.
Available Pancreatin Formulations
The Cafoli Lifecare Pancreatin range comprises 8 formulations in the following dosage forms:
Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the current Pancreatin price list.
Therapeutic Applications of Pancreatin
Prescribed under medical supervision for:
- Pancreatic exocrine insufficiency, including in chronic pancreatitis
- Malabsorption and steatorrhoea due to inadequate pancreatic enzyme secretion
- Digestive support following pancreatic or gastrointestinal surgery
- Cystic fibrosis-related pancreatic insufficiency
- Functional dyspepsia, flatulence and bloating, as part of enzyme combinations
Prescriber specialties: gastroenterologists, consulting physicians, general surgeons and paediatricians. Pancreatin is taken with meals as directed by the treating doctor.
Why Pancreatin is a High-Potential Molecule for Distributors
Pancreatin serves two very different markets from one shelf, and both are attractive for different reasons. At the specialist end, pancreatic exocrine insufficiency — from chronic pancreatitis, pancreatic surgery or cystic fibrosis — is a permanent condition: the pancreas does not recover, so enzyme replacement is taken with every meal, for life. That is about as durable a repeat-prescription base as exists in gastroenterology. At the general end, enzyme combinations for indigestion, bloating and heavy-meal dyspepsia address a complaint that a very large share of the Indian population experiences regularly, giving high retail volume and strong OTC-style pull. The category also rewards manufacturing quality in a way most generics do not: because the enzymes are destroyed without proper enteric coating, a WHO-GMP product genuinely outperforms a poorly made one, and prescribers notice. That gives a franchise partner a credible clinical argument rather than a price argument.
Why Choose Cafoli Lifecare
- Monopoly rights — exclusive district-wise marketing rights for the Pancreatin range
- WHO-GMP certified manufacturing and DCGI-approved products
- Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
- 1000+ franchise partners across India with an on-time dispatch record
- Transparent net rates and dedicated franchise support
References
- PubChem — Pancreatin record
- PubMed — Pancreatic enzyme replacement therapy
- MedlinePlus — Pancreatitis
Our formulations of Pancreatin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: